SEC Form 4 · accession 0001209191-15-033114
Karyopharm Therapeutics Inc. · KPTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ran Frenkel
Officer — EVP, WW Development Operations
Period of report
Apr 6, 2015
Accepted (ET)
Apr 8, 2015 · 4:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001503802
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 6, 2015 | P | 1,000 | $29.43 | A | 1,000 | D | |
| Common Stock | Apr 7, 2015 | P | 2,000 | $33.00 | A | 3,000 | D |
Table II — derivative securities
No Table II lines on this filing.